NCT05223556

Brief Summary

This is a prospective clinical study. At the Shaoguan Diabetic Eye Screening Programme, patients ages 30-80 will undergo the two diagnostic models: (1) in a remote diagnostic clinic site, patients undergo a self-testing device that provides both color retinal photography (CRP) and optical coherence tomography (OCT) imaging of nondilated pupils, and receive an online consultation provided by a retinal specialist; (2) on a separate day, patients visit the tertiary hospital, undergo traditional imaging of dilated pupils acquired by a non-expert imager using a traditional CRP imaging device at the point of care, and receive a face-to-face consultation provided by a retinal specialist. Within one week of receiving both diagnostic imaging services, patient preferences are assessed and they decide which diagnostic imaging model is preferred.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
167

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 4, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

April 4, 2023

Status Verified

February 1, 2023

Enrollment Period

11 months

First QC Date

January 22, 2022

Last Update Submit

March 30, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Accuracy in the diagnosis of referral retinal lesions

    Accuracy in the diagnosis of referral retinal lesions using the self-testing diagnosis imaging

    1 week

Secondary Outcomes (4)

  • The agreement between the two modalities

    1 week

  • Feasibility of self-testing diagnosis imaging model

    1 week

  • Feasibility of self-testing diagnosis imaging model

    1 week

  • Satisfaction of participants as measured by questionnaire

    1 week

Study Arms (1)

Shaoguan Diabetic cohort

Patients with diabetes ages 30-80 were enrolled in Shaoguan Diabetic Eye Screening Programme, who will receive diabetic retinopathy screening both in a remote diagnostic imaging site and in a tertiary hospital

Device: Full Self-Diagnostic device in a remote diagnostic imaging siteDevice: Human imager operated diagnostic device in the hospital

Interventions

Full Self-Diagnostic CRP+OCT imaging, followed by online consultation

Shaoguan Diabetic cohort

Human imager operated CRP imaging with dilated pupils, followed by face-to-face consultation

Shaoguan Diabetic cohort

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants from Shaoguan diabetic cohort

You may qualify if:

  • who are enrolled in the Shaoguan Diabetic Eye Screening Programme for their eye check-up
  • who are diagnosed with diabetes and aged between 30 years and 80 years
  • be able to sit for an imaging device for image acquisition
  • be capable of giving their own consent

You may not qualify if:

  • \. who are pregnant or nursing women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510060, China

Location

MeSH Terms

Conditions

Diabetic Retinopathy

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2022

First Posted

February 4, 2022

Study Start

February 1, 2022

Primary Completion

December 30, 2022

Study Completion

December 30, 2022

Last Updated

April 4, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations